SEC Form 4/A · accession 0001213900-18-013895
Lifeward Ltd. · LFWD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
Jeff Dykan
Director
Period of report
Apr 30, 2018
Accepted (ET)
Oct 15, 2018 · 9:16 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001607962
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary shares, par value NIS 0.01 per shareF1,F2 | Apr 30, 2018 | A | 22,727 | $0.00 | A | 28,749 | I | ESOP |
| Ordinary shares, par value NIS 0.01 per shareF3,F4,F5 | holding | — | — | — | 1,500,100 | I | By partnership |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The Reporting Person is amending the Form 4 filed on May 2, 2018, which, due to administrative error, inadvertently reported two grants of 22,727 ordinary shares, par value NIS per share ("Ordinary Shares"), issuable upon the vesting of restricted stock units ("RSUs"). The Reporting Person received only one grant of such RSUs. The Reporting Person is also amending this Form 4 to file as an exhibit a signed authorization of the attorney-in-fact.
- F2Represents 22,727 Ordinary Shares issuable upon the vesting of RSUs granted on April 30, 2018 under the ReWalk Robotics Ltd. 2014 Equity Incentive Plan. The RSUs vest in four equal quarterly installments starting three months following the date of grant.
- F3The Reporting Person is a director of SCP Vitalife II GP, Ltd. ("SCP Vitalife GP"), which is the sole general partner of SCP Vitalife II Associates, L.P. ("SCP Vitalife Associates"). SCP Vitalife Associates is the sole general partner of each of SCP Vitalife Partners II, L.P. ("SCP Vitalife") and SCP Vitalife Israel Partners (Israel) II, L.P. ("SCP Vitalife Israel"), the direct beneficial owner of the Ordinary Shares. The Reporting Person disclaims beneficial ownership within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise of the Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, except to the extent of his pecuniary interest therein.
- F4SCP Vitalife Associates, as the general partner of SCP Vitalife and SCP Vitalife Israel, may be deemed to beneficially own 1,357,574 Ordinary Shares, which consist of 1,017,674 and 339,900 Ordinary Shares held by SCP Vitalife and SCP Vitalife Israel, respectively. SCP Vitalife GP is the general partner of SCP Vitalife Associates and, as such, shares voting and dispositive power over, and may be deemed to beneficially own, the Ordinary Shares held by the foregoing entities. The Reporting Person shares voting and dispositive power over, and may be deemed to beneficially own 1,500,100 Ordinary Shares, which consist of the Ordinary Shares as set forth in footnote (7) to this Form 4.
- F5Consists of 1,357,574 Ordinary Shares held by the foregoing entities due to the Reporting Person serving as a director of SCP Vitalife GP, as well as (i) 62,006 Ordinary Shares held by Vitalife Partners (Overseas) L.P., (ii) 20,506 Ordinary Shares held by Vitalife Partners (Israel) L.P., (iii) 20,733 Ordinary Shares held by Vitalife Partners (D.C.M) L.P. ("Vitalife Partners DCM", and together with Vitalife Partners (Overseas) L.P. and Vitalife Partners (Israel) L.P., the "Vitalife I Entities") and (iv) 39,281 Ordinary Shares currently held by the Office of the Chief Scientist of the State of Israel ("OCS"), that the Vitalife I Entities have the right to acquire from the OCS, due to the Reporting Person serving as a director of Vitalife Life Sciences Ltd., the general partner of Vitalife Partners Management L.P., which is the general partner of each of the Vitalife I Entities.
Remarks
Exhibit 24.1 - Power of Attorney